top of page
Search

Kratom in 2025: History, Effects, Benefits, Risks, and the 7-OH Debate (Facts Only)


A person holding large green kratom leaves with text overlay that reads: “Kratom in 2025: History, effects, benefits, risks and the 7-OH debate (facts only)"

Quick summary


  • Kratom (Mitragyna speciosa) is a Southeast Asian tree whose leaves have been used for generations for energy and pain relief. In the U.S., it’s sold as powders, capsules, teas, and drinks. PMCDEA Diversion Control Division

  • The FDA says kratom is not lawfully marketed in the U.S. as a drug, dietary supplement, or food; enforcement has focused on adulteration, safety, and unproven medical claims. U.S. Food and Drug Administration

  • Two key alkaloids are mitragynine (most abundant) and 7-hydroxymitragynine (7-OH) (trace amounts in leaf, also a metabolite). 7-OH is far more potent at the μ-opioid receptor than mitragynine and even morphine in animal models. Nature+1ScienceDirect

  • Highly concentrated or semi-synthetic 7-OH products (gummies, shots, “extracts”) have drawn fresh FDA action and warning letters in 2025; several states are also tightening rules. U.S. Food and Drug Administration+1StatelineAxios

  • Reported benefits include mood/energy support, pain relief, and help with opioid withdrawal for some; risks include dependence, withdrawal, interactions, and—rarely—severe toxicity, especially with other drugs. National Institute on Drug Abuse (NIDA) IRP


A brief history: From village leaf to global controversy


In northern Malaysia and southern Thailand, laborers traditionally chewed fresh kratom leaves or brewed tea to work longer hours, ease aches, and improve mood. This customary use dates back many decades. PMCDEA Diversion Control Division

As kratom spread to the West, products shifted from leaves/tea to powders, capsules, and extracts—with significant variability in alkaloid content and quality control, which complicates safety and regulation. Nature


How kratom works (in plain English)


Kratom’s effects come mainly from mitragynine and 7-OH, which bind to opioid receptors but act differently from classic opioids in some lab tests. 7-OH is much more potent than mitragynine; mitragynine can be converted to 7-OH in the body (shown in animals and supported by human PK data). NaturePMCMDPI


Typical natural content

  • Mitragynine: ~1–6% of leaf material (varies by sample/product)

  • 7-OH: ~0.01–0.04% (trace)That gap matters: most traditional preparations deliver very little 7-OH compared with some modern extracts. Nature


Reported benefits (what users and some studies say)


  • Pain relief & mood/energy support. Many U.S. users report functional benefits; real-time diary data from a 2024 NIDA study found most participants integrated use without major short-term problems (note: this doesn’t negate risks). NIDA IRP

  • Withdrawal management. Some use kratom to self-manage opioid withdrawal symptoms; evidence is mixed and largely observational. Federal health agencies do not approve kratom for this purpose. National Institute on Drug Abuse


Important caveat: Benefits are not established by FDA-approved trials, and products vary widely in strength and purity. U.S. Food and Drug Administration


Known risks and adverse effects


  • Dependence & withdrawal. Regular use can lead to tolerance and withdrawal (anxiety, insomnia, irritability, GI upset) on cessation. National Institute on Drug Abuse

  • Interactions. Co-use with opioids, benzodiazepines, alcohol, or sedatives increases risk (sedation, respiratory depression). Poison center data show many adverse events involve multiple substances. CDC

  • Serious events (uncommon but documented). Case reports and surveillance describe seizures, liver injury, and a small fraction of overdose deaths with kratom detected—often with other drugs on board. CDC

  • Quality concerns. Past microbial contamination and adulteration outbreaks underscore the need for testing and transparency. U.S. Food and Drug Administration


7-OH vs. natural kratom: What’s the real difference?


What is 7-OH?


  • 7-hydroxymitragynine (7-OH) occurs naturally in trace amounts in kratom leaves and is also a metabolite of mitragynine. It has much higher μ-opioid receptor potency than mitragynine and even morphine in animal assays. Nature+1PMC


Why the concern now?


  • In 2025, FDA actions and warning letters targeted concentrated/semi-synthetic 7-OH products (e.g., shots, gummies, “enhanced” extracts) marketed in convenience channels. These products can deliver 7-OH far above natural leaf levels, raising abuse potential and overdose risk, especially with other depressants. U.S. Food and Drug Administration+1


Bottom line difference


  • Natural kratom: Dominated by mitragynine, very low 7-OH content; effects vary by dose/strain, and risks rise with heavy use or mixing drugs. Nature

  • 7-OH-forward/semi-synthetic products: Pharmacologically much stronger, faster-acting, and more addictive potential; currently the primary focus of FDA scrutiny. NatureU.S. Food and Drug Administration

While 7-OH does exist naturally in tiny amounts, the commercial 7-OH products drawing headlines are manufactured or concentrated far beyond natural levels—and carry a high potential for abuse. U.S. Food and Drug Administration

Laws & policy: Patchwork in 2025


  • Federal: FDA maintains kratom is not lawfully marketed as a drug, dietary supplement, or food; recent actions specifically target 7-OH products. U.S. Food and Drug Administration+1

  • States: Regulations vary widely—some bans, many Kratom Consumer Protection Act-style laws (age limits, labeling, testing). Recent activity includes Colorado’s 2025 advisory and new restrictions. A national overview shows rapidly evolving state rules. AxiosStateline


What we see in treatment settings (facts, not a stance)


  • Two patterns are emerging:

    1. People who turned to kratom while reducing or avoiding opioids and later seek help for kratom dependence; and

    2. People who escalated from natural leaf products to high-potency 7-OH/extract drinks developed rapid tolerance and withdrawal. (This aligns with broader reporting and 2025 policy responses.) Wall Street Journal


At Mantra Recovery, we don’t take a side on kratom approval. Our focus is practical: safety, transparency, and evidence-based support for anyone who feels their use (of kratom or 7-OH products) is getting unmanageable.


Harm-reduction facts (not medical advice)


  • Avoid mixing kratom with opioids, benzos, alcohol, or sedatives. Most severe events involve combinations. CDC

  • Be wary of “extract” or “enhanced” products, especially those advertising 7-OH; these are the highest risk for dependence and adverse events. U.S. Food and Drug Administration

  • Look for third-party testing and clear alkaloid labeling if choosing to use natural kratom products. The FDA has not approved kratom for any medical use. U.S. Food and Drug Administration

  • If you experience withdrawal, cravings, or lost control, reach out—there are supportive, nonjudgmental ways to stabilize and plan next steps.


FAQ


Is kratom an opioid? Not in the classical sense, but key alkaloids activate opioid receptors, which explains both benefits (analgesia) and risks (dependence, withdrawal). Nature

Can kratom use be fatal? Deaths with kratom detected are rare relative to other drugs, and often involve polysubstance use; nevertheless, fatalities have been documented. CDC

Is 7-OH the same as kratom? No. 7-OH is a minor natural constituent and metabolite of kratom, but commercial 7-OH products can be semi-synthetic/concentrated and vastly more potent than natural leaf. NaturePMCU.S. Food and Drug Administration

Is kratom legal? Federally, kratom is not lawfully marketed as a drug, supplement, or food; state laws vary (age limits, testing, or bans). Check local regulations. U.S. Food and Drug Administration Stateline


Sources & further reading


How Mantra Recovery can help (compassion first, judgment last)


Suppose kratom—or a 7-OH/extract product—has started to take over more than it gives. In that case, we can help you map options that fit your goals: stabilization, taper planning, medical evaluation for polysubstance risks, or a family-centered intervention if a loved one is struggling.


—This article is informational and not medical advice. If you have symptoms like severe sedation, trouble breathing, chest pain, or seizures, call emergency services immediately.

 
 
 

Comments

bottom of page